We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ACHFF market cap is 84.7M. The company's latest EPS is CAD -0.0515 and P/E is -35.53.
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 93k | 68k | 3.89M | 965k | 1.98M |
| Operating Income | -2.2M | -4.16M | -548k | -797k | -2.55M |
| Net Income | -2.36M | -4.63M | -1.17M | -1.41M | -3.33M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 567k | 741k | 2.67M | 621k | 1.17M |
| Total Liabilities | 3.47M | 4.61M | 6.55M | 5.09M | 6.68M |
| Total Equity | -2.9M | -3.87M | -3.88M | -4.47M | -5.51M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -1.8M | -1.91M | -2.98M | 479k | -234k |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 1.66M | 2.16M | 2.78M | -421k | 559k |
| Market Cap | 84.7M |
| Price to Earnings Ratio | -35.53 |
| Price to Sales Ratio | 59.61 |
| Price to Cash Ratio | 141.86 |
| Price to Book Ratio | -21.47 |
| Dividend Yield | - |
| Shares Outstanding | 64.65M |
| Average Volume (1 week) | 7.77k |
| Average Volume (1 Month) | 13.1k |
| 52 Week Change | 61.74% |
| 52 Week High | 1.88 |
| 52 Week Low | 0.7909 |
| Spread (Intraday) | 0.03 (2.26%) |
| Company Name | ARch Biopartners Inc (QB) |
| Address |
27 st. clair avenue east toronto, ontario M5V 1M1 |
| Website | https://archbiopartners.com |
| Industry | advertising agencies (7311) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
